AbbVie, Genomics Medicine Ireland and WuXi NextCODE Announce Landmark Population Genomics Alliance - Seite 3
About Genomics Medicine Ireland
Founded in 2015, Genomics Medicine Ireland (GMI) is an Irish life-sciences company leading large-scale, population-based genome research studies on the
island of Ireland examining the relationship between genetics, health and disease. It is building a preeminent disease-specific database of population
genomics. GMI works in collaboration with clinicians, patients, academic researchers and global biotech and pharmaceutical sectors to discover pathways to new treatments and new
diagnostics for people both here in Ireland and around the world.
GMI's partners include investors ARCH Venture Partners, Polaris Partners, GV (formerly Google Ventures), the Ireland Strategic Investment Fund, and corporate partner Amgen and its subsidiary deCODE genetics. Collectively, they bring multi-decade experience in disease genomics to GMI. www.genomicsmed.ie
About WuXi NextCODE
WuXi NextCODE is a fully integrated global contract genomics organization. With offices in Shanghai; Kendall
Square in Cambridge, Massachusetts; and Reykjavik, Iceland, we offer comprehensive services that enable population,
precision medicine, diagnostics and wellness initiatives and enterprises to use the genome to improve health around the world. Our capabilities span study design, sequencing, secondary analysis,
storage, and interpretation and scalable analytics – all backed by the most proven and widely used technology for organizing, mining and sharing genome sequence data. We are also applying the same
capabilities to advance a growing range of sequence-based tests and scans in China. WuXi NextCODE is a subsidiary of WuXi AppTec. Visit us on the web at
wuxinextcode.com.
Contacts: |
|
|
Genomics Medicine Ireland |
AbbVie |
WuXi NextCODE |
Celine Crawford |
Adelle Infante |
Edward Farmer, PhD |
MKC Communications |
Adelle.infante@abbvie.com |
efarmer@wuxinextcode.com |
celine@mkc.ie |
847.938.8745 |
+1 781 775 6206 |
+353 1 703 8600 |
|
|
Photo - http://mma.prnewswire.com/media/266982/wuxinextcode__leading_genomics_01.jpg
Photo - http://mma.prnewswire.com/media/454977/WuXi_NextCODE_abbvie.jpg
Photo - http://mma.prnewswire.com/media/454978/WuXi_GMI.jpg
Lesen Sie auch